Key Takeaways
- • Bill Ackman, billionaire hedge fund manager and Pershing Square founder, is committing $400 million to establish the Ackman Oxman Institute, a brain research, treatment, and rehabilitation facility in Manhattan's West 60s neighborhood spanning 3.4 acres.
- • The initiative was catalyzed by Ackman's 26-year-old daughter Lucy's February 2026 massive brain hemorrhage, which left her temporarily blind and unable to speak; she has since regained mobility and comprehension and continues rehabilitation.
- • Ackman is funding the institute via an initial donation of 10 million shares of Pershing Square stock (valued at approximately $400 million), structured as a nonprofit and named jointly for his family and his wife Neri Oxman, an Israeli-American MIT professor and technology designer.
- • The institute will operate independently from traditional universities, with Ackman citing concerns about academic institutions' focus on "politics outweighing meritocracy," campus disruptions, and antisemitism as factors in the decision to build a standalone research organization.
- • The facility will adopt a "patient-centric" model focused on brain research, rehabilitation, recovery, human optimization, and longevity, positioning itself as a dedicated alternative to university-based neuroscience programs.
Summary
Billionaire hedge fund manager Bill Ackman announced on August 20, 2026, the creation of a $400 million brain research and treatment institute in Manhattan following his daughter's near-fatal medical crisis earlier this year. In February 2026, Lucy Ackman, 26, suffered a massive brain hemorrhage that resulted in temporary blindness and an inability to speak. According to Ackman's public statements, Lucy has since made substantial progress in her recovery, regaining the ability to walk short distances and comprehend her surroundings, though rehabilitation continues.
The new organization, named the Ackman Oxman Institute, will be headquartered on 3.4 acres in Manhattan's West 60s, where Ackman has already purchased two large buildings and an adjacent vacant lot. The institute is being funded through an initial donation of 10 million shares of Pershing Square Holdings stock, valued at approximately $400 million according to public filings. Ackman is partnering with his wife, Neri Oxman—a renowned Israeli-American technology designer and former MIT professor—in establishing the nonprofit institution.
The institute's stated mission centers on brain research, rehabilitation, recovery, human optimization, and longevity services, with a deliberate emphasis on patient-centric care. A significant strategic element of the announcement involves Ackman's decision to operate the institute independently rather than in partnership with traditional universities. Ackman cited multiple concerns with academic institutions, including the prioritization of "politics over meritocracy," learning disruptions caused by campus protests, and what he described as persistent antisemitism on university campuses as driving factors in this structural choice.
This initiative represents both a personal philanthropical response to family circumstances and a substantive capital commitment to neuroscience infrastructure. The scale of the investment and the high-profile leadership involved position the Ackman Oxman Institute as a potential significant player in brain research and neurorehabilitation within the institutional medical research landscape.
The new organization, named the Ackman Oxman Institute, will be headquartered on 3.4 acres in Manhattan's West 60s, where Ackman has already purchased two large buildings and an adjacent vacant lot. The institute is being funded through an initial donation of 10 million shares of Pershing Square Holdings stock, valued at approximately $400 million according to public filings. Ackman is partnering with his wife, Neri Oxman—a renowned Israeli-American technology designer and former MIT professor—in establishing the nonprofit institution.
The institute's stated mission centers on brain research, rehabilitation, recovery, human optimization, and longevity services, with a deliberate emphasis on patient-centric care. A significant strategic element of the announcement involves Ackman's decision to operate the institute independently rather than in partnership with traditional universities. Ackman cited multiple concerns with academic institutions, including the prioritization of "politics over meritocracy," learning disruptions caused by campus protests, and what he described as persistent antisemitism on university campuses as driving factors in this structural choice.
This initiative represents both a personal philanthropical response to family circumstances and a substantive capital commitment to neuroscience infrastructure. The scale of the investment and the high-profile leadership involved position the Ackman Oxman Institute as a potential significant player in brain research and neurorehabilitation within the institutional medical research landscape.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.